Loading...
Auxly Cannabis Group Inc.
XLY.TO•TSX
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.14
CA$0.005(3.85%)
Auxly Cannabis Group Inc. (XLY.TO) Financial Performance & Income Statement Overview
Review Auxly Cannabis Group Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
21.02%
↑ 21.02%
Operating Income Growth
177.42%
↑ 177.42%
Net Income Growth
63.27%
↑ 63.27%
Operating Cash Flow Growth
104.26%
↑ 104.26%
Operating Margin
13.99%
↑ 13.99%
Gross Margin
45.68%
↑ 45.68%
Net Profit Margin
16.78%
↑ 16.78%
ROE
18.87%
↑ 18.87%
ROIC
12.78%
↑ 12.78%
Auxly Cannabis Group Inc. (XLY.TO) Income Statement & Financial Overview
Review Auxly Cannabis Group Inc.'s (XLY.TO) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $34.63M | $33.28M | $29.18M | $25.24M |
| Cost of Revenue | $17.22M | $16.14M | $23.13M | $19.79M |
| Gross Profit | $17.40M | $17.15M | $6.04M | $5.45M |
| Gross Profit Ratio | $0.50 | $0.52 | $0.21 | $0.22 |
| R&D Expenses | $0.00 | $108000.00 | $0.00 | $135000.00 |
| SG&A Expenses | $10.66M | $9.67M | $10.01M | $10.55M |
| Operating Expenses | $11.38M | $17.15M | $10.01M | $10.55M |
| Total Costs & Expenses | $28.60M | $33.28M | $23.26M | $30.34M |
| Interest Income | $27000.00 | $54000.00 | $140000.00 | $19000.00 |
| Interest Expense | $2.29M | $3.13M | $2.75M | $6.71M |
| Depreciation & Amortization | $2.33M | $2.58M | $2.85M | $2.52M |
| EBITDA | $8.46M | $8.95M | $7.70M | -$630000.00 |
| EBITDA Ratio | $0.24 | $0.27 | $0.26 | -$0.02 |
| Operating Income | $6.02M | $0.00 | $5.92M | -$5.10M |
| Operating Income Ratio | $0.17 | $0.00 | $0.20 | -$0.20 |
| Other Income/Expenses (Net) | -$1.60M | $3.24M | -$3.92M | -$7.69M |
| Income Before Tax | $4.42M | $3.24M | $2.002M | -$10.02M |
| Income Before Tax Ratio | $0.13 | $0.10 | $0.07 | -$0.40 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $15.99M |
| Net Income | $4.42M | $3.24M | $2.002M | -$26.01M |
| Net Income Ratio | $0.13 | $0.10 | $0.07 | -$1.03 |
| EPS | $0.004 | $0.003 | $0.002 | -$0.03 |
| Diluted EPS | $0.004 | $0.002 | $0.002 | -$0.03 |
| Weighted Avg Shares Outstanding | $1.28B | $1.27B | $1.25B | $1.02B |
| Weighted Avg Shares Outstanding (Diluted) | $1.38B | $1.35B | $1.30B | $1.02B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan